Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ibuprofen versus oral ketorolac for children with musculoskeletal injury
2018-004057-25Phase 3Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute pain, musculoskeletal injuries, orthopaedic trauma and 1 more comparing Oral ibuprofen with Oral ketorolac (2 arms). Primary endpoint: Pain reduction at 60 minutes. Started Feb 2021; status: completed.
02
Drugs
ibuprofenketorolac
03
Conditions
acute painmusculoskeletal injuriesorthopaedic traumaExtremity Injuries
Beyond the preview
Go deeper on 2018-004057-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004057-25.